Buscar
Charles River Laboratories International Inc
CRLAñadir a la lista de seguimiento
234.300USD
-0.500-0.21%
Cierre 07-29 16:00（ET）Cotizaciones retrasadas 15 min
11.29BCap. mercado
PérdidaP/E TTM
Más Datos de Charles River Laboratories International Inc Compañía
Charles River Laboratories International, Inc. is a drug development company. It provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions around the globe accelerate their research and drug development efforts. Its Research Models and Services segment includes three businesses that provide foundational tools that enable its clients to discover new molecules: Research Models, Research Model Services, and Cell Solutions. Its Discovery and Safety Assessment segment provides regulated and non-regulated DSA services to support the research, development, and regulatory-required safety testing of potential new drugs, including therapeutic discovery and optimization plus in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development. Its Manufacturing Solutions segment includes Microbial Solutions and Biologics Solutions.
Información de Charles River Laboratories International Inc
Símbolo de cotizaciónCRL
Nombre de la empresaCharles River Laboratories International Inc
Fecha de salida a bolsaJun 23, 2000
Director ejecutivoFoster (James C)
Número de empleados18600
Tipo de seguridadOrdinary Share
Fin del año fiscalJun 23
Dirección251 Ballardvale St
CiudadWILMINGTON
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal01887
Teléfono17812226000
Sitio Webhttps://www.criver.com/
Símbolo de cotizaciónCRL
Fecha de salida a bolsaJun 23, 2000
Director ejecutivoFoster (James C)
Ejecutivos de Charles River Laboratories International Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Birgit Girshick
Ms. Birgit Girshick
Chief Operating Officer, Corporate Executive Vice President
Chief Operating Officer, Corporate Executive Vice President
58.79K
-5.76%
Mr. James C. Foster
Mr. James C. Foster
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
26.98K
-920.54%
Ms. Victoria L. (Vicky) Creamer
Ms. Victoria L. (Vicky) Creamer
Corporate Executive Vice President, Chief People Officer
Corporate Executive Vice President, Chief People Officer
20.94K
+19.00%
Mr. Joseph W. LaPlume
Mr. Joseph W. LaPlume
Corporate Executive Vice President - Corporate Development and Strategy
Corporate Executive Vice President - Corporate Development and Strategy
14.72K
+26.15%
Ms. Shannon M. Parisotto
Ms. Shannon M. Parisotto
Corporate Executive Vice President - Discovery and Safety Assessment
Management
Corporate Executive Vice President - Discovery and Safety Assessment
Management
10.72K
-14.26%
Ms. Virginia M. (Gina) Wilson, CPA
Ms. Virginia M. (Gina) Wilson, CPA
Independent Director
Independent Director
6.35K
+22.65%
Ms. Reshema Kemps-Polanco
Ms. Reshema Kemps-Polanco
Independent Director
Independent Director
4.56K
+43.24%
Dr. Craig B. Thompson, M.D.
Dr. Craig B. Thompson, M.D.
Independent Director
Independent Director
3.85K
+37.34%
Mr. Abraham N. (Abe) Ceesay
Mr. Abraham N. (Abe) Ceesay
Independent Director
Independent Director
2.38K
+60.32%
Mr. Paul W. Graves
Mr. Paul W. Graves
Independent Director
Independent Director
2.38K
+60.32%
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Birgit Girshick
Ms. Birgit Girshick
Chief Operating Officer, Corporate Executive Vice President
Chief Operating Officer, Corporate Executive Vice President
58.79K
-5.76%
Mr. James C. Foster
Mr. James C. Foster
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
26.98K
-920.54%
Ms. Victoria L. (Vicky) Creamer
Ms. Victoria L. (Vicky) Creamer
Corporate Executive Vice President, Chief People Officer
Corporate Executive Vice President, Chief People Officer
20.94K
+19.00%
Mr. Joseph W. LaPlume
Mr. Joseph W. LaPlume
Corporate Executive Vice President - Corporate Development and Strategy
Corporate Executive Vice President - Corporate Development and Strategy
14.72K
+26.15%
Ms. Shannon M. Parisotto
Ms. Shannon M. Parisotto
Corporate Executive Vice President - Discovery and Safety Assessment
Management
Corporate Executive Vice President - Discovery and Safety Assessment
Management
10.72K
-14.26%
Ms. Virginia M. (Gina) Wilson, CPA
Ms. Virginia M. (Gina) Wilson, CPA
Independent Director
Independent Director
6.35K
+22.65%
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Charles River Laboratories International Inc?
Los cinco principales accionistas de Charles River Laboratories International Inc son: Ms. Birgit Girshick
¿Cuántas instituciones poseen acciones de Charles River Laboratories International Inc (CRL)?
A fecha de 2026Q1, 1429 instituciones poseen acciones de Charles River Laboratories International Inc, con un valor de mercado combinado de aproximadamente 56.13M, lo que representa el 116.51% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -7963916.00.
¿Cuál es la mayor fuente de ganancias de Charles River Laboratories International Inc?
El 2026Q1, el segmento empresarial DSA generó la ganancia más alta para Charles River Laboratories International Inc, ascendiendo a 2.40B y representando el 59.84% de la ganancia total.